CL2022001169A1 - Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto - Google Patents

Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto

Info

Publication number
CL2022001169A1
CL2022001169A1 CL2022001169A CL2022001169A CL2022001169A1 CL 2022001169 A1 CL2022001169 A1 CL 2022001169A1 CL 2022001169 A CL2022001169 A CL 2022001169A CL 2022001169 A CL2022001169 A CL 2022001169A CL 2022001169 A1 CL2022001169 A1 CL 2022001169A1
Authority
CL
Chile
Prior art keywords
cation exchange
exchange chromatography
high salt
product related
related impurities
Prior art date
Application number
CL2022001169A
Other languages
English (en)
Spanish (es)
Inventor
Natalia Gomez
Malhar R Ambhaikar
Benjamin J Tillotson
Luis Diaz
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2022001169A1 publication Critical patent/CL2022001169A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CL2022001169A 2019-11-07 2022-05-04 Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto CL2022001169A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962931874P 2019-11-07 2019-11-07

Publications (1)

Publication Number Publication Date
CL2022001169A1 true CL2022001169A1 (es) 2023-01-27

Family

ID=73598212

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2022001169A CL2022001169A1 (es) 2019-11-07 2022-05-04 Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto
CL2024001792A CL2024001792A1 (es) 2019-11-07 2024-06-14 Métodos purificación proteínas con lavados altos en nacl en cromatografía intercambio catiónico

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2024001792A CL2024001792A1 (es) 2019-11-07 2024-06-14 Métodos purificación proteínas con lavados altos en nacl en cromatografía intercambio catiónico

Country Status (14)

Country Link
US (1) US20220372071A1 (enExample)
EP (1) EP4055042A1 (enExample)
JP (2) JP2022554283A (enExample)
KR (1) KR20220092958A (enExample)
CN (1) CN114651007A (enExample)
AR (1) AR120398A1 (enExample)
AU (1) AU2020377919A1 (enExample)
BR (1) BR112022008782A2 (enExample)
CA (1) CA3160208A1 (enExample)
CL (2) CL2022001169A1 (enExample)
IL (1) IL292602A (enExample)
MX (1) MX2022005594A (enExample)
TW (2) TW202523676A (enExample)
WO (1) WO2021091933A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024500747A (ja) * 2020-12-18 2024-01-10 キニクサ ファーマシューティカルズ， リミテッド タンパク質組成物ならびにそれを産生及び使用するための方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9034298A (en) * 1997-08-25 1999-03-16 Walter H. Runkis A simple, environmentally benign, method for purifying protein
CN105315323A (zh) * 2007-10-30 2016-02-10 健泰科生物技术公司 通过阳离子交换层析进行的抗体纯化
WO2010127069A1 (en) * 2009-04-29 2010-11-04 Schering Corporation Antibody purification
US20120238730A1 (en) * 2011-03-15 2012-09-20 Abbott Laboratories Integrated approach to the isolation and purification of antibodies
CN104628846B (zh) * 2013-11-06 2019-12-06 三生国健药业（上海）股份有限公司 重组蛋白质的纯化方法
EP3145951A1 (en) * 2014-06-24 2017-03-29 InSight Biopharmaceuticals Ltd. Methods of purifying antibodies
RS65573B1 (sr) * 2014-08-04 2024-06-28 Hoffmann La Roche Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije
CA2963692A1 (en) * 2014-10-09 2016-04-14 Engmab Ag Bispecific antibodies against cd3epsilon and ror1
JP6699085B2 (ja) * 2015-03-25 2020-05-27 東ソー株式会社 Ｆｃ結合性タンパク質の精製方法
TWI798179B (zh) * 2016-06-17 2023-04-11 美商建南德克公司 多特異性抗體之純化
WO2018237159A1 (en) * 2017-06-21 2018-12-27 Cephalon, Inc. Cation exchange chromatography wash buffer
CN110305217B (zh) * 2018-03-27 2022-03-29 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Also Published As

Publication number Publication date
AU2020377919A1 (en) 2022-06-16
TW202523676A (zh) 2025-06-16
TW202132323A (zh) 2021-09-01
MX2022005594A (es) 2022-06-09
EP4055042A1 (en) 2022-09-14
US20220372071A1 (en) 2022-11-24
CN114651007A (zh) 2022-06-21
KR20220092958A (ko) 2022-07-04
CL2024001792A1 (es) 2024-11-08
TWI878377B (zh) 2025-04-01
IL292602A (en) 2022-07-01
AR120398A1 (es) 2022-02-09
WO2021091933A1 (en) 2021-05-14
JP2026048656A (ja) 2026-03-17
BR112022008782A2 (pt) 2022-07-26
JP2022554283A (ja) 2022-12-28
CA3160208A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
RS67828B1 (sr) Konfiguracija za proizvodnju olefina
SG11202103485PA (en) Low beam headlights
HUE055703T2 (hu) Eljárás hialuronsav tisztítására
EP4014502A4 (en) SCALING METHOD FOR ENCODER BLOCK
ZA202109175B (en) Novel peptide compound or pharmaceutically acceptable salt thereof
EP4410773A3 (en) Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid
SG11202103001PA (en) Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
MX373659B (es) Metodo para producir un pentapeptido sintetico.
BR112016013157A2 (pt) peptídeos resistentes à protease
PL3737470T3 (pl) Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści gpr40
IL281761A (en) Process of making calcium alpha-ketoglutarate
PL3272760T3 (pl) Ligandy 1,1'-bis(fosfino)ferrocenowe dla alkoksykarbonylowania
PL3823952T3 (pl) Oczyszczanie kwasu lewulinowego
SG11202007168TA (en) Industrial process for continuously synthesizing alkane-sulphonic acid
MX2022005594A (es) Lavados de salinidad elevada durante cromatografia de intercambio cationico para eliminar impurezas relacionadas con el producto.
MY198138A (en) Process For Pd-Catalyzed Hydroxycarbonylation Of Diisobutene: Ratio Of 3,5,5-Trimethylhexanoic Acid/H2O
MX381459B (es) Metodo de manufactura de proteina.
GB2576235B (en) Workbench system
SG11202101575TA (en) Process for the production of high purity isobutylene
MX2019005785A (es) Proceso para la purificacion de 1-(4-clorofenil)pirazol-3-ol.
WO2016202808A3 (en) NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES
PT3441429T (pt) Soluções de sal de leucoindigo aquoso purificado concentrado
MX2020010343A (es) Proceso para la purificacion de biocomposiciones complejas.
IT201900025186A1 (it) Metodo per la purificazione di cisteammina
CL2022001168A1 (es) Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto